Stay updated with breaking news from Ablation System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management, and post-operative pain management, today announced that it will...
The REBALANCE-HF trial at HFSA 2023 reveals that right greater splanchnic nerve ablation was well-tolerated and safe in patients with HFpEF, with additional analysis shedding light on the proportion of responders to the procedure.
Minerva Surgical, Inc. (NASDAQ:UTRS – Get Free Report)’s stock price hit a new 52-week low on Monday . The company traded as low as $2.77 and last traded at $2.89, with a volume of 10521 shares traded. The stock had previously closed at $3.29. Minerva Surgical Stock Performance The stock has a market cap of […]
Minerva Surgical, Inc. (NASDAQ:UTRS – Free Report)’s stock is going to reverse split on Monday, October 2nd. The 1-20 reverse split was announced on Monday, October 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, October 2nd. Minerva Surgical Stock Performance Minerva Surgical stock remained flat at […]
Minerva Surgical, Inc. (NASDAQ:UTRS – Free Report) shares are set to reverse split before the market opens on Monday, October 2nd. The 1-20 reverse split was announced on Monday, October 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, October 2nd. Minerva Surgical Price Performance NASDAQ UTRS […]